The vaccines market is projected to reach USD 50.42 billion by 2023 from USD 36.45 billion in 2018, at a CAGR of 6.7% during the forecast period.
How will the focus on therapeutic vaccines create opportunities for growth for the overall vaccines market?
Therapeutic vaccines enable corrective treatment, as opposed to preventive vaccines. An improved understanding of immunology has resulted in the opportunity to develop these therapeutic vaccines for the treatment of cancer, allergies, physiological disorders, and infectious diseases. Such diseases have a large patient base that desperately seeks alternative treatments due to the toxicity of chemotherapy and radiotherapy. In this regard, a number of companies are developing therapeutic vaccines and conducting clinical trials to study their safety. In June 2017, Inovio Pharmaceuticals, Inc. (US) completed phase II clinical trials for the VGX-3100 DNA vaccine. The vaccine is being evaluated for use in human papillomavirus-caused cervical dysplasia, cervical cancer, head and neck cancer, and anogenital cancers. In January 2017, Genocea Biosciences (US) announced the positive clinical results of its ongoing placebo-controlled Phase IIb trial analyzing the GEN-003 vaccine for the treatment of HSV-2 or genital herpes. The development of therapeutic vaccines, given their benefits, may ensure strong growth prospects for players.
Download PDF Brochure – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1155
Is inadequate access to vaccines still a key challenge faced by players in the market?
This is a key issue in the market, particularly in poverty-stricken regions where awareness programs and initiatives have either not penetrated sufficiently or failed to penetrate entirely. In other cases, vaccines may not be easily accessible, such as in remote regions, due to a lack of sufficient storage facilities and government support. Other factors, such as low literacy rates and a lack of health education and financial resources, have also restrained access to immunization.
According to the WHO, in 2016, around 19.5 million infants globally were unable to access routine immunization services. This poses significant challenges for the global vaccines market by directly affecting the availability and uptake of products. Until awareness on and the availability of vaccines grow globally, it will continue to hinder the overall market growth.
Request for Sample Pages – https://www.marketsandmarkets.com/requestsampleNew.asp?id=1155
Browse Related Reports:
Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases, Porcine Parvovirus), Type (Poultry, Companion Animal, Aquaculture, Porcine), Technology (Toxoid, Recombinant, Inactivated) – Global Forecast to 2022
Healthcare Distribution Market by Type (Pharmaceutical (Brand-name, Generic, OTC, Vitamins), Medical Device, Biopharmaceutical (Vaccines, Monoclonal Antibodies)), End User (Retail Pharmacies, Hospital Pharmacies) – Global Forecasts to 2024
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Shelly Singh
Email: Send Email
Phone: 1-888-600-6441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html